title: Lung lavage for meconium aspiration syndrome in newborn infants.
abstract: BACKGROUND
  Meconium aspiration syndrome (MAS) can occur when a newborn infant inhales a mixture of meconium and amniotic fluid into the lungs around the time of delivery. Other than supportive measures, little effective therapy is available. Lung lavage may be a potentially effective treatment for MAS by virtue of removing meconium from the airspaces and altering the natural course of the disease.
  
  
  OBJECTIVE
  To evaluate the effects of lung lavage on morbidity and mortality in newborn infants with MAS.
  
  
  METHODS
  We searched the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library), MEDLINE, and EMBASE up to December 2012; previous reviews including cross-references, abstracts, and conference proceedings; and expert informants. We contacted authors directly to obtain additional data. We used the following subject headings and text words: meconium aspiration, pulmonary surfactants, fluorocarbons, bronchoalveolar lavage, lung lavage, pulmonary lavage.
  
  
  METHODS
  Randomised controlled trials that evaluated the effects of lung lavage in infants with MAS, including those intubated for the purpose of lavage. Lung lavage was defined as any intervention in which fluid is instilled into the lung that is followed by an attempt to remove it by suctioning and/or postural drainage.
  
  
  METHODS
  The review authors extracted from the reports of the clinical trial, data regarding clinical outcomes, including mortality, requirement for extracorporeal membrane oxygenation (ECMO), pneumothorax, duration of mechanical ventilation and oxygen therapy, length of hospital stay, indices of pulmonary function, and adverse effects of lavage. Data analysis was done in accordance with the standards of the Cochrane Neonatal Review Group.
  
  
  RESULTS
  Only four small randomised controlled trials fulfilled the selection criteria. For one of these trials, no data are available for the control group. Two studies compared lavage using diluted surfactant with standard care. Meta-analysis of these two studies did not show a significant effect on mortality (typical relative risk 0.42, 95% confidence interval [CI] 0.12 to 1.46; typical risk difference -0.10, 95% CI -0.24 to 0.04) or the use of ECMO (typical relative risk 0.27, 95% CI 0.04 to 1.86; typical risk difference -0.15, 95% CI -0.35 to 0.04). For the composite outcome of death or use of ECMO, a significant effect favoured the lavage group (typical relative risk 0.33, 95% CI 0.11 to 0.96; typical risk difference -0.19, 95% CI -0.34 to -0.03; number needed to benefit [NNTB] 5). No other benefits were reported. The other published study compared surfactant lavage followed by a surfactant bolus with surfactant bolus therapy alone in MAS complicated by pulmonary hypertension. No significant improvements in mortality, pneumothorax, duration of mechanical ventilation. or duration of hospitalisation were observed.
  
  
  CONCLUSIONS
  In infants with meconium aspiration syndrome, lung lavage with diluted surfactant may be beneficial, but additional controlled clinical trials of lavage therapy should be conducted to confirm the treatment effect, to refine the method of lavage treatment, and to compare lavage treatment with other approaches, including surfactant bolus therapy. Long-term outcomes should be evaluated in further clinical trials.
authors: Department of Medicine, Seoul National University College of Medicine, Seoul, Korea, South. hahns@snu.ac.kr.
authors: Seokyung
authors: S
authors: Hahn
authors: Hyun Jin
authors: HJ
authors: Choi
authors: Roger
authors: R
authors: Soll
authors: Peter A
authors: PA
authors: Dargaville
mesh_terms: D018893:Bronchoalveolar Lavage / Q000379:methods*; D006801:Humans; D007231:Infant, Newborn; D008471:Meconium Aspiration Syndrome / Q000401:mortality / Q000628:therapy*; D011663:Pulmonary Surfactants / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D011663:Pulmonary Surfactants
references: J Perinatol. 2008 Dec;28 Suppl 3:S56-66
references: 19057612
references: Am J Obstet Gynecol. 1976 Nov 15;126(6):712-5
references: 984149
references: Minn Med. 1973 Dec;56(12):1031-5
references: 4760246
references: Pediatrics. 1999 May;103(5 Pt 1):1014-8
references: 10224181
references: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD002054
references: 17636695
references: Acta Paediatr. 2004 Jan;93(1):60-5
references: 14989441
references: Z Geburtshilfe Neonatol. 2002 Jan-Feb;206(1):15-8
references: 11887250
references: Pediatr Clin North Am. 1993 Oct;40(5):955-81
references: 8414717
references: J Appl Physiol (1985). 1987 Feb;62(2):429-37
references: 3558203
references: Am J Obstet Gynecol. 1991 Feb;164(2):477-81
references: 1992687
references: Acta Paediatr Jpn. 1995 Feb;37(1):64-7
references: 7754769
references: Am J Respir Crit Care Med. 2003 Aug 15;168(4):456-63
references: 12714351
references: J Paediatr Child Health. 2007 Jul-Aug;43(7-8):539-45
references: 17635682
references: Neonatology. 2012;101(3):183-91
references: 22067375
references: Przegl Lek. 2002;59 Suppl 1:21-4
references: 12108066
references: Acta Paediatr Jpn. 1994 Jun;36(3):236-8
references: 8091968
references: Pediatr Res. 1992 Jun;31(6):625-8
references: 1635826
references: Intensive Care Med. 1998 May;24(5):501-8
references: 9660268
references: Pediatrics. 1996 Jan;97(1):48-52
references: 8545223
references: Acta Paediatr. 2005 Jul;94(7):896-902
references: 16188812
references: Pediatrics. 1978 Oct;62(4):454-9
references: 714576
references: J Pediatr. 2001 Jan;138(1):113-5
references: 11148523
references: Pediatr Res. 1980 Jan;14(1):34-8
references: 7360519
references: Pediatrics. 2000 Jan;105(1 Pt 1):1-7
references: 10617696
references: Pediatr Res. 1998 Nov;44(5):705-15
references: 9803452
references: Neonatology. 2008;94(3):160-3
references: 18612212
references: Pediatr Pulmonol. 1999 Jul;28(1):18-23
references: 10406046
references: Intensive Care Med. 1996 Dec;22(12):1412-3
references: 8986496
references: J Pediatr. 2011 Mar;158(3):383-389.e2
references: 20947097
references: J Pediatr. 1998 Jan;132(1):40-7
references: 9469998
references: Wien Klin Wochenschr. 1987 Dec 18;99(24):843-7
references: 3439183
references: J Formos Med Assoc. 2003 May;102(5):326-30
references: 12874671
references: Pediatrics. 2002 Jun;109(6):1081-7
references: 12042546